Keywords: profit, plummets, solvay, recession, belgian, pharmaceuticals, chemicals
Profit plummets 55% for Solvay in recession
Article | 15 May 2009
Belgian pharmaceuticals and chemicals firm Solvay posted first-quarter 2009 net profit down 55%, year-on-year, due to generic competition for cannabinoid drug Marinol ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
